#CMSC17

June 19, 2017June 19, 2017

National MS Society Highlights Diet, Lifestyle Research Focusing on Living Well With Multiple Sclerosis

News

The National Multiple Sclerosis (MS) Society has selected research highlights from a recent MS conference in an effort to help make living with the disease less burdensome. Presentations from the ... Read more

June 5, 2017June 5, 2017

MS News That Caught My Eye: An Acne Drug, a High-Cost Gel, Good News About Lemtrada, and Getting Off MS Drugs

Columns, The MS Wire - A Column by Ed Tobias

In case you missed them, here are some news stories that appeared in MS News Today that caught my eye over the past week. Acne Therapy Reduces ... Read more

June 2, 2017June 2, 2017

#CMSC17 – Ocrevus, Progressive MS and Other Research Highlights: An Interview with CMSC’s Robert Lisak

News

The recent annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC) brought researchers and healthcare professionals to New Orleans to discuss advances — and obstacles to advances ... Read more

May 31, 2017May 31, 2017

#CMSC17 – Lemtrada’s 2 Year Therapy in RRMS Sustains Efficacy for Over 6 Years Without Additional Treatment

News

Taking Lemtrada (alemtuzumab) for two years inhibited magnetic resonance imaging (MRI) disease activity in patients with relapsing-remitting multiple sclerosis (RRMS) for more than six years, the CARE-MS I ... Read more

May 31, 2017May 31, 2017

#CMSC17 – Many Caregivers of MS Patients Say the Disease Exhausts Them Physically and Emotionally

News

Most people who care for multiple sclerosis (MS) patients are happy to be caregivers, but they admit that their own emotional and physical health — as ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Physical Activity Halts Depression in Young MS Patients, Canadian Study Shows

News

Young multiple sclerosis (MS) patients who engage in physical activity can relieve symptoms of depression, concludes a Canadian study supported by the National Multiple Sclerosis Society. Researchers ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Ocrevus Lowers MS Relapse Rates Even Further in Extension Study

News

Multiple sclerosis patients who benefited from Ocrevus (ocrelizumab) in two Phase 3 clinical trials continued to benefit when they extended their treatment, researchers reported. In fact, their annual ... Read more

May 30, 2017October 30, 2017

#CMSC17 – Celgene’s Investigational Therapy Ozanimod Safe, Effective in Treating Relapsing MS, Clinical Trial Finds

News

Long-term treatment for up to 12o weeks, with the investigational drug Ozanimod (RPC-1063), found to be effective and safe in patients with relapsing multiple sclerosis (MS) who ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Rituxan-treated MS Patients Three Times More Likely to Have Improved Brain Scans

News

Multiple sclerosis patients who start Rituxan (rituximab) treatment are three times more likely to have unchanged or improved brain-scan readings than worse ones, according to a ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Review Suggests Certain MS Patient Groups May Discontinue Disease-Modifying Treatments

News

Older patients with secondary progressive multiple sclerosis (SPMS) as well as older relapsing patients whose MS has been inactive after five years may safely discontinue their ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Cladribine Reduced Annual MS Relapse Rate by 55% to 57%, Trials Show

News

Cladribine tablets reduced relapsing multiple sclerosis patients’ annual relapse rate by 55 to 57 percent, depending on the dose, according to clinical trials. EMD Serono, a ... Read more

May 26, 2017May 26, 2017

#CMSC17 – Tysabri Improves Mental Outlook for Patients with Secondary Progressive Multiple Sclerosis

News

Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple sclerosis (SPMS), according to results of a Biogen-supported study with patients ... Read more

May 26, 2017May 26, 2017

#CMSC17 – MS Patients Should Contribute to Outcome Measure Development, Study Argues

News

Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have differing perceptions of how crucial various measures are, a new ... Read more

May 26, 2017May 26, 2017

#CMSC17 – Feeling of Social Stigma Makes Depression in MS More Likely, Study Reports

News

People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression,  research presented at the Consortium of Multiple Sclerosis ... Read more

May 26, 2017May 26, 2017

#CMSC17 – Relapse After First Lemtrada Course No Indication of Poor Long-Term Outcome, Study Finds

News

Multiple sclerosis (MS) patients who experienced a relapse between their first and second rounds of Lemtrada (alemtuzumab) had good treatment outcomes over the long run, according ... Read more

May 26, 2017May 26, 2017

#CMSC17 – MS Mobile Apps Link Clinicians and Patients, Improving Disease Management, Study Says

News

The use of multiple sclerosis (MS) mobile apps by patients and their clinicians encourages shared decision-making and helps patients improve their outcomes, finds a study presented ... Read more

May 26, 2017May 26, 2017

#CMSC17 – Single Session of Ball-throwing Exercise Improves Balance Control in MS, Study Shows

News

Patients with relapsing-remitting multiple sclerosis (RRMS) regain part of their balance control after a single training session of ball-throwing exercises, finds a study supported by the ... Read more

May 26, 2017

#CSMC17 in Photos: What’s Happening At The Meeting

The Consortium of Multiple Sclerosis Centers (CMSC) focuses on improvements and advancements in care for those living with multiple sclerosis. Typically hosting more than 2,000 attendees and 70 exhibitors, ... Read more

May 26, 2017May 26, 2017

#CMSC17 – Genentech Starts Site to Connect MS Patients and Caregivers with Resources

News

Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can help them. The company unveiled GatherMS at the annual meeting of ... Read more

May 1, 2017May 26, 2017

#CMSC17 – Experts to Focus on MS Patient Care at CMSC Annual Meeting in New Orleans

News

The 31st Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) will take place May 24-27 at the Ernest N. Morial Convention Center in New Orleans. ... Read more

December 6, 2016May 26, 2017

Consortium of Multiple Sclerosis Centers Calls for Abstracts for 2017 Annual Meeting

News

The Consortium of Multiple Sclerosis Centers (CMSC) is inviting researchers and healthcare professionals to submit abstracts to be presented at its 31st Annual Meeting, focusing on developments in multiple ... Read more